Landmark decision from Sweden: Throws Pfizer and Moderna COVID-19 mRNA vaccines in the trash - The reasons

In a landmark decision that shatters the narrative of multinational Pharma and causes tremors across the global healthcare establishment, Sweden moves forward. From the 2027/2028 period, the country fully and irrevocably abolishes mRNA technology vaccines for COVID-19, turning exclusively toward traditional, protein-based products. With this move, Sweden becomes the first country on the planet to permanently close its door to experimental genetic products from Pfizer/BioNTech and Moderna, discarding in the trash the technology that was imposed worldwide. The decision was sealed through official national procurement tenders, as revealed by Swedish pharmaceutical media (LäkemedelsVärlden, Läkemedelsmarknaden), confirming that the nightmare mRNA experiment is heading toward its end, impacting mRNA technology procurement.

Genetic intervention vs Traditional technology: Hidden risks revealed

The chaotic difference between the two technologies now brings to light dangerous side effects that were silenced for years:

• Classic Protein Vaccines (e.g., Nuvaxovid) Based on proven, traditional technology. The body receives the spike protein ready and laboratory-produced alongside an adjuvant, developing antibodies naturally without any dangerous intervention in human cellular machinery.

• mRNA Genetic Vaccines (Comirnaty et al.) Instead of a ready antigen, they introduce a genetic message into the human organism, transforming recipient cells into production factories for the toxic spike protein, altering vaccine safety profiles.

The result: Organisms and humans destroyed

According to a plethora of independent scientific analyses and studies, the violent imposition of mRNA technology is linked with terrifying biological risks that the scientific community hid under the rug:

• Uncontrolled toxin production The quantity and time duration of spike protein production by human cells are entirely uncontrolled, transforming the organism into a time bomb.

• Dangerous organ dissemination Lipid nanoparticles (LNPs) carrying the mRNA do not remain in the arm muscle, as "experts" claimed. They aggressively diffuse into the bloodstream and invade vital organs, causing a wave of autoimmune diseases and severe injury.

• Lipid toxicity The synthetic lipid coating proves particularly reactive and toxic, linked directly in literature to a disproportionate number of severe side effects and sudden incidents recorded globally, straining public health safety.

Stockholm uncovers the global narrative

Sweden proves once again that it refuses to succumb to multinational dictates. It is recalled that it was the sole country to stand tall at the start of the pandemic, rejecting crushing lockdowns, curfews, and school closures—a strategy mocked back then by systemic media, but triumphantly vindicated in hindsight. With the final withdrawal of mRNA vaccines, Sweden takes the step that other governments fear taking: listening at last to voices of independent doctors (such as the Doctors' Collective) and scientists shouting about the danger of experimental genetic products, bringing a definitive end to the mRNA era, reshaping pandemic policy evaluation.

Sweden opts for coronavirus protein vaccine instead of mRNA From the 2027/2028 season onwards, Sweden will use only a protein-based coronavirus vaccine for its national vaccination campaign. It is the first country in the world to say goodbye to the mRNA vaccines. Difference in technology Nuvaxovid is a classic protein vaccine. It contains a ready-made piece of the virus (the spike protein), produced using recombinant technology (a molecular method in which DNA from different organisms is combined in the laboratory and placed into a host cell (such as a bacterium or yeast) to allow it to multiply or produce proteins) and provided with an adjuvant (an excipient that stimulates and strengthens the body's immune response to the antigen, so that the vaccine works better). The body is presented with this protein directly to build an immune response. This differs from mRNA vaccines (such as Comirnaty from Pfizer/BioNTech), where the body's cells must produce the spike protein themselves after receiving the mRNA instruction. This process carries the risk of autoimmune reactions, especially because these products do not remain at the injection site but can spread throughout the body. Furthermore, the quantity and duration of spike protein production are not defined in the mRNA technique. In addition, the lipid coating of the mRNA vaccines is very reactive. All in all, this leads to a disproportionate number of side effects, some very serious and resulting in death (1-3). Sweden chose its own path during the coronavirus years by not enforcing lockdowns or school closures. Although there was much criticism of this at the time, the Swedish approach was later appreciated ( De Morgen, 25 December 2023 ). With the decision to phase out coronavirus mRNA vaccines, Sweden appears set to play a pioneering role once again. The Doctors' Collective, together with European partners, has been advocating for the cessation of mRNA vaccinations for quite some time. Sources: Sanofi press release (April 21, 2026), LäkemedelsVärlden report and Läkemedelsmarknaden report regarding the tender. References Cappelletti-Montano B, Demuru G, Laconi E and Musio M (2023) A comparative analysis on serious adverse events reported for COVID-19 vaccines in adolescents and young adults. Front. Public Health 11:1145645. doi: 10.3389/fpubh.2023.1145645 Szebeni, J. Expanded Spectrum and Increased Incidence of Adverse Events Linked to COVID-19 Genetic Vaccines: New Concepts on Prophylactic Immuno-Gene Therapy, Iatrogenic Orphan Disease, and Platform-Inherent Challenges. Pharmaceutics 2025, 17, 450. Fraiman J, Erviti J, Jones M, Greenland S, Whelan P, Kaplan RM, Doshi P. Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults. Vaccine. 2022 Sep 22;40(40):5798-5805. doi: 10.1016/j.vaccine.2022.08.036. Epub 2022 Aug 31. PMID: 36055877; PMCID: PMC9428332. https://t.co/4i78xL9zA0

— Wafik S. El-Deiry, MD, PhD, FACP (@weldeiry) October 26, 2026

Sales collapse and billions in stock

The Swedish decision arrives as a coup de grâce at a time when public trust in mRNA vaccines has plummeted globally. Data from European pharmaceutical warehouses reveal that millions of Pfizer and Moderna doses remained unwanted and were led to destruction, as citizens massively refused to continue booster vaccinations. Stockholm, viewing the deadlock and absolute degradation of these products by society, chooses to permanently terminate golden contracts, refusing to continue fueling Big Pharma coffers with public money, halting pharmaceutical supply agreements.

The "wall of silence" around side effects and legal prosecutions

At the exact moment Sweden turns its back on mRNA, a wave of legal actions swells in many countries worldwide from individuals who suffered severe injury following product administration. Incidents of myocarditis, pericarditis, neurological disorders, and aggressive thrombosis, which in early years were branded "rare coincidences" by official bodies, are now officially recorded in international literature. The Swedish pivot to protein vaccines is interpreted by many as an indirect yet crystal-clear admission by health authorities that the safety profile of genetic vaccines proved exceptionally problematic, raising medical liability claims.

The domino effect terrifying Brussels

What now sparks panic across European decision-making centers is the risk of a generalized "domino effect." Sweden, a nation holding top scientific prestige and tradition in health sciences, sets a dangerous precedent for the European Union. If additional member states follow Stockholm's example and demand the cancellation of centralized mRNA procurements, Brussels' widely heralded vaccination strategy will collapse like a house of cards, exposing those who signed multi-year, secret agreements with pharmaceutical giants, altering European health governance.

www.bankingnews.gr